Cardiff Oncology IncCRDF
Price$1.18

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $508K-25.6% YoYTTM through 30 Jun 2026
Net Income -$40.1MTTM through 30 Jun 2026
Free Cash Flow -$40.9MTTM through 30 Jun 2026

Margins

Current
Operating Margin-31,363.4%
Net Margin-7,884.1%

Returns

-129.0%ROE
-91.1%ROA

Balance Sheet Health

Debt / Equity0.02x
Current Ratio3.27x
Net Debt-$122.3Mnet cash position
Cash & Equivalents$9.2M

Quality Metrics

Altman Z-Score-14.11
Piotroski F-Score1 / 9
FCF Margin-8,050.8%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25
FY2025: $593K
Diluted EPS-$0.60TTM
'18'20'21'22'23'24'25
FY2025: $-0.69

Dividend

No dividend

Capital Allocation

Capex Intensity8.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.